United States · FDA National Drug Code directory

Novartis Pharmaceuticals Corporation

Labeler · 175 source records

The organisation role is retained from the source. Companies with similar names in other sources are not automatically merged.

United States · Source reference 0078-0493_fd5dd3b3-6bdf-437e-a763-1a07f9631121

Focalin XR

CAPSULE, EXTENDED RELEASE / Novartis Pharmaceuticals Corporation

United States · Source reference 0078-0608_fd5dd3b3-6bdf-437e-a763-1a07f9631121

Focalin XR

CAPSULE, EXTENDED RELEASE / Novartis Pharmaceuticals Corporation

United States · Source reference 0078-0609_fd5dd3b3-6bdf-437e-a763-1a07f9631121

Focalin XR

CAPSULE, EXTENDED RELEASE / Novartis Pharmaceuticals Corporation

United States · Source reference 0078-0607_160c27a2-4788-441a-ac42-674e5aec433b

Gilenya

CAPSULE / Novartis Pharmaceuticals Corporation

United States · Source reference 0078-0965_160c27a2-4788-441a-ac42-674e5aec433b

Gilenya

CAPSULE / Novartis Pharmaceuticals Corporation

United States · Source reference 0078-0401_2b30c65b-bf6e-4a30-9754-585d500d59f3

Gleevec

TABLET / Novartis Pharmaceuticals Corporation

United States · Source reference 0078-0649_2b30c65b-bf6e-4a30-9754-585d500d59f3

Gleevec

TABLET / Novartis Pharmaceuticals Corporation

United States · Source reference 0078-1490_2b30c65b-bf6e-4a30-9754-585d500d59f3

Gleevec

TABLET / Novartis Pharmaceuticals Corporation

United States · Source reference 0078-0674_e6e4f66b-e398-44d3-a832-e5a809f3e861

HYCAMTIN

INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION / Novartis Pharmaceuticals Corporation

United States · Source reference 0078-0743_4e6e6db9-e1cf-83cb-e063-6294a90a2420

ILEVRO

SUSPENSION/ DROPS / Novartis Pharmaceuticals Corporation

United States · Source reference 0078-0734_a09d3635-1735-4ac9-884e-5c49897da6f5

Ilaris

INJECTION, SOLUTION / Novartis Pharmaceuticals Corporation

United States · Source reference 0078-0654_028e6158-3b78-41dd-99a8-6acb582f7245

Jadenu

TABLET, FILM COATED / Novartis Pharmaceuticals Corporation

United States · Source reference 0078-0655_028e6158-3b78-41dd-99a8-6acb582f7245

Jadenu

TABLET, FILM COATED / Novartis Pharmaceuticals Corporation

United States · Source reference 0078-0656_028e6158-3b78-41dd-99a8-6acb582f7245

Jadenu

TABLET, FILM COATED / Novartis Pharmaceuticals Corporation

United States · Source reference 0078-0713_028e6158-3b78-41dd-99a8-6acb582f7245

Jadenu

GRANULE / Novartis Pharmaceuticals Corporation

United States · Source reference 0078-0720_028e6158-3b78-41dd-99a8-6acb582f7245

Jadenu

GRANULE / Novartis Pharmaceuticals Corporation

United States · Source reference 0078-0727_028e6158-3b78-41dd-99a8-6acb582f7245

Jadenu

GRANULE / Novartis Pharmaceuticals Corporation

United States · Source reference 0078-1007_ab75831e-d802-456a-bae6-7c85ef8dc3ed

KESIMPTA

INJECTION, SOLUTION / Novartis Pharmaceuticals Corporation

United States · Source reference 0078-0860_9466e642-f230-43f3-b78e-5a432fa040ee

KISQALI

TABLET, FILM COATED / Novartis Pharmaceuticals Corporation

United States · Source reference 0078-0867_9466e642-f230-43f3-b78e-5a432fa040ee

KISQALI

TABLET, FILM COATED / Novartis Pharmaceuticals Corporation

United States · Source reference 0078-0874_9466e642-f230-43f3-b78e-5a432fa040ee

KISQALI

TABLET, FILM COATED / Novartis Pharmaceuticals Corporation

United States · Source reference 0078-0846_381f1ba3-f115-424f-9890-75eb06ab6666

KYMRIAH

INJECTION, SUSPENSION / Novartis Pharmaceuticals Corporation

United States · Source reference 0078-0958_381f1ba3-f115-424f-9890-75eb06ab6666

KYMRIAH

INJECTION, SUSPENSION / Novartis Pharmaceuticals Corporation

United States · Source reference 0078-1000_e4109fce-9d82-4800-8eae-fed97097241f

LEQVIO

INJECTION, SOLUTION / Novartis Pharmaceuticals Corporation

United States · Source reference 0078-1224_8683b06e-4901-4526-89ad-23a8fe2d1331

LOCAMETZ

INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION / Novartis Pharmaceuticals Corporation

United States · Source reference 0078-1049_956e925d-695b-46c9-94e9-ce88ac51dfb3

Lamprene

CAPSULE, LIQUID FILLED / Novartis Pharmaceuticals Corporation

United States · Source reference 0078-0364_b9db75d9-9d1e-4b2d-9876-5f5520feaecc

Lotrel

CAPSULE / Novartis Pharmaceuticals Corporation

United States · Source reference 0078-0379_b9db75d9-9d1e-4b2d-9876-5f5520feaecc

Lotrel

CAPSULE / Novartis Pharmaceuticals Corporation

United States · Source reference 0078-0405_b9db75d9-9d1e-4b2d-9876-5f5520feaecc

Lotrel

CAPSULE / Novartis Pharmaceuticals Corporation

United States · Source reference 0078-0406_b9db75d9-9d1e-4b2d-9876-5f5520feaecc

Lotrel

CAPSULE / Novartis Pharmaceuticals Corporation

Browse companies in United States →